
Opinion|Videos|September 20, 2024
AI and the Future of Biomarkers in Prostate Cancer
Prostate cancer specialists share their insights on anticipated future advancements that could significantly influence prostate cancer management strategies.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- What future advancements in testing protocols do you anticipate, and how might they impact the management of prostate cancer?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Unmet needs and emerging solutions in MRI-guided prostate cancer care
2
HHS requests testosterone therapy label updates, citing new safety data
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
5
















